postmenopausal


Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to postmenopausal: Postmenopausal Bleeding

post·men·o·paus·al

 (pōst′mĕn-ə-pô′zəl)
adj.
Of or occurring in the time following menopause.

postmenopausal

(ˌpəʊstmɛnəʊˈpɔːzəl)
adj
(Gynaecology & Obstetrics) existing or taking place after the menopause
ThesaurusAntonymsRelated WordsSynonymsLegend:
Adj.1.postmenopausal - subsequent to menopause
Translations

postmenopausal

adj posmenopáusico
References in periodicals archive ?
While guidelines advise that women 65 and older be screened, as should younger postmenopausal women with risk factors, in clinical practice this often means that younger postmenopausal women with normal baseline BMD will enter into "autopilot" and undergo testing every 2 years.
com announces that a new market research report is available in its catalogue: EpiCast Report: Postmenopausal Vaginal Atrophy - Epidemiology Forecast to 2022
ALL IT takes is a peg of alcohol or two to keep bones of a postmenopausal women healthy, a new study has revealed.
A new, one-year, double-blind controlled clinical study shows that cacao-flavonoids and soy isoflavones can significantly improve biomarkers of CVD risk in postmenopausal women with type 2 diabetes.
Washington, June 17 (ANI): A new study has found that the use of hormone replacement therapy (HRT) in postmenopausal women can significantly reduce the prevalence of peripheral arterial disease (PAD).
Vitamin K2, raloxifene, and bisphosphonates, such as etidronate, alendronate, and risedronate, are widely used in the treatment of postmenopausal osteoporosis in Japan.
Salivary Testosterone Testing in Postmenopausal Women Receiving Testosterone Treatment
Bone loss in women increases significantly during the late perimenopausal period and may reach more than 2% annually in the early postmenopausal period, particularly in the more hormonally sensitive lumbar spine (trabecular bone).
These data provide, for the first time, objective findings to support this common sleep complaint in postmenopausal women," asserted Edward O.
The FDA has approved Evista (raIoxifene hydrochloride) for reducing the risk of invasive breast cancer in postmenopausal women with osteoporosis and in postmenopausal women at high risk for invasive breast cancer.
Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
Weight gain or loss had little impact on women who had taken postmenopausal hormones.

Full browser ?